THYMIC CANCER

Clinical trials for THYMIC CANCER explained in plain language.

Never miss a new study

Get alerted when new THYMIC CANCER trials appear

Sign up with your email to follow new studies for THYMIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

New hope for rare thymus cancers: experimental drug PT-112 enters trial

Disease control Recruiting now

This study tests a drug called PT-112 in people with thymoma or thymic cancer that has come back or worsened after standard treatment. The drug aims to shrink tumors by killing cancer cells and boosting the immune system. About 53 adults will receive PT-112 infusions in 28-day cy…

Matched conditions: THYMIC CANCER

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

THYMIC CANCER

Get alerted when new THYMIC CANCER trials appear

New hope for rare thymus cancers: experimental drug PT-112 enters trial